Hemophagocytic lymphohistiocytosis associated with a parvovirus B19 infection during pregnancy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 25004318.
- Also identified by DOI 10.1097/AOG.0000000000000385.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hemophagocytic lymphohistiocytosis is potentially fatal. Prompt diagnosis and initiation of treatment are critical for ensuring the best possible prognosis. We present a case of parvovirus B19 infection related to hemophagocytic lymphohistiocytosis during pregnancy. The patient experienced fever and pancytopenia. A bone marrow biopsy demonstrated hemophagocytosis and a giant proerythroblasts, which is characteristic of a parvovirus B19 infection. Viral serology for parvovirus B19 was positive. Prompt treatment was started because of the high level of certainty of viral-associated hemophagocytic lymphohistiocytosis, and the patient was successfully treated with prednisolone administration. She delivered a healthy newborn without any complications. Hemophagocytic lymphohistiocytosis should be considered when encountering unexplained cytopenia and fever. Prednisolone was an effective treatment.
Medical subject headings
- Lymphohistiocytosis, Hemophagocytic
- Parvoviridae Infections
- Parvovirus B19, Human
- Pregnancy Complications, Infectious